ethacridine has been researched along with misoprostol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Batioglu, S; Gökmen, O; Senöz, S; Urkütür, M; Yapar, EG | 1 |
Erdemoglu, E; Inan, I; Kelekci, S | 1 |
Boza, AV; Castillo, LS; de León, RG; Mariño, DR; Mitchell, EM | 1 |
Chen, Q; Cheng, L; Fang, A; Hou, S; Zhang, L | 1 |
Chen, OJ; Chen, QF; Cheng, LN; Fang, AH; Hou, SP; Huang, YM | 1 |
Chen, WL; Jin, L; Li, L; Liu, XY; Peng, P | 1 |
Du, S; Li, R; Long, Q; Tang, F; Wu, S; Zhao, Y | 1 |
Chen, Y; Xu, Y; Yang, P; Zhang, L | 1 |
1 review(s) available for ethacridine and misoprostol
Article | Year |
---|---|
Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials.
Topics: Abortifacient Agents; Abortion, Induced; China; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2011 |
3 trial(s) available for ethacridine and misoprostol
Article | Year |
---|---|
Second trimester pregnancy termination including fetal death: comparison of five different methods.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adult; Catheterization; Dinoprostone; Ethacridine; Female; Fetal Death; Humans; Infusions, Intravenous; Misoprostol; Oxytocics; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 1996 |
Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Ethacridine; Female; Humans; Infusions, Intravenous; Misoprostol; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Proportional Hazards Models; Prospective Studies; Treatment Outcome | 2006 |
Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized clinical trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Chi-Square Distribution; China; Ethacridine; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Young Adult | 2010 |
4 other study(ies) available for ethacridine and misoprostol
Article | Year |
---|---|
Misoprostol preferable to ethacridine lactate for abortions at 13-20 weeks of pregnancy: Cuban experience.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Confidence Intervals; Cuba; Ethacridine; Female; Humans; Misoprostol; Odds Ratio; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Treatment Outcome | 2008 |
Clinical analyses of 66 cases of mid-trimester pregnancy termination in women with prior cesarean.
Topics: Abortion, Induced; Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimesters; Retrospective Studies; Uterine Rupture | 2015 |
The method for termination of mid-trimester pregnancy with placenta previa: A case study.
Topics: Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Placenta; Placenta Previa; Pregnancy; Retrospective Studies | 2022 |
Clinical analysis of the regimens for terminating the second-trimester pregnancy in cesarean section women.
Topics: Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2023 |